Stock Overview
Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare · Biotechnology
Roivant Sciences Ltd is a Healthcare company with a market capitalization of $24.51B.
Market Cap
$24.51B
Price/Sales
2,966.8
Price/Book
5.4
EV/EBITDA
0.7
Beta
1.14
EPS (TTM)
$-0.54
Profit Margin
0.0%
ROE
-7.6%
52W High
$34.68
52W Low
$10.71
5-Year Price History
Latest Annual Financials · FY ending March 31, 2026
Revenue
$8.26M
Gross Profit
$6.97M
Operating Income
-$1.29B
Net Income
-$299.77M
Free Cash Flow
-$758.56M
Total Debt
$11.15M
Cash & Equivalents
$1.42B
Shareholder Equity
$4.53B
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q4 2026 | May 20, 2026 | $-0.32 | $-0.35 | +8.6% |
| Q3 2025 | February 6, 2026 | $-0.24 | $-0.31 | +22.6% |
| Q2 2025 | November 10, 2025 | $-0.28 | $-0.30 | +6.7% |
| Q1 2025 | August 11, 2025 | $-0.25 | $-0.23 | -8.7% |
| Q4 2025 | May 29, 2025 | $-0.29 | $-0.26 | -10.3% |
| Q3 2024 | February 10, 2025 | $0.23 | $-0.28 | +182.1% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Roivant Sciences Ltd's market cap?
As of June 29, 2026, Roivant Sciences Ltd (ROIV) has a market capitalization of $24.51B.
Does Roivant Sciences Ltd pay a dividend?
Roivant Sciences Ltd does not currently pay a dividend.
What sector is ROIV in?
Roivant Sciences Ltd is in the Healthcare sector, specifically the Biotechnology industry.
What was Roivant Sciences Ltd's revenue?
In its latest reported fiscal year (ending March 31, 2026), Roivant Sciences Ltd reported revenue of $8.26M and net income of -$299.77M.
Ask your own questions about ROIV
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.